Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson's Disease.
Parkinson's disease
UKBB
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
26 Mar 2024
26 Mar 2024
Historique:
revised:
21
02
2024
received:
10
08
2023
accepted:
23
02
2024
medline:
27
3
2024
pubmed:
27
3
2024
entrez:
27
3
2024
Statut:
aheadofprint
Résumé
Modifiable risk factors for Parkinson's disease (PD) are poorly known. The aim is to evaluate independent associations of different nutritional components, physical activity, and sedentary behavior and metabolic factors with the risk of PD. In this population-based prospective cohort study using the data of the United Kingdom Biobank (from 2006-2010), 502,017 men and women who were free from PD (International Classification of Diseases 10th edition; "G20") at baseline were included. We implemented a Cox proportion hazard's model to evaluate the associations of different levels of physical activity, sitting time, sleep habits, diet quality, alcohol and coffee consumption, smoking, and body mass index with PD risk, adjusting for several confounding variables. During a median follow-up of 12.8 years, lifestyle factors including vigorous physical activity (hazard ration [HR] = 0.84; 95% confidence interval [CI], 0.75-0.94), low-to-moderate sitting time (HR = 0.89; 95% CI, 0.81-0.97), and high sleep quality (HR = 0.89; 95% CI, 0.80-0.99) were associated with a reduced risk of PD. Small amounts of coffee (HR = 0.88; 95% CI, 0.82-0.95), red meat (HR = 0.86; 95% CI, 0.76-0.97), and current smoking (HR = 0.65; 95% CI, 0.56-0.75) were also associated with a lower risk of PD, whereas alcohol intake (HR = 1.29; 95% CI, 1.06-1.56) with higher PD risk. Secondary analysis, including metabolic risk factors, confirmed these findings and highlighted the potential protective effect of plasma vitamin D and uric acid, but of low-density lipoprotein-cholesterol, triglycerides, and C-reactive protein as well. Vigorous physical activity, reduced sitting time, good sleep quality together with small coffee intake and vitamin D supplementation are potentially neuroprotective lifestyle interventions for the prevention of PD. © 2024 International Parkinson and Movement Disorder Society.
Sections du résumé
BACKGROUND
BACKGROUND
Modifiable risk factors for Parkinson's disease (PD) are poorly known.
OBJECTIVES
OBJECTIVE
The aim is to evaluate independent associations of different nutritional components, physical activity, and sedentary behavior and metabolic factors with the risk of PD.
METHODS
METHODS
In this population-based prospective cohort study using the data of the United Kingdom Biobank (from 2006-2010), 502,017 men and women who were free from PD (International Classification of Diseases 10th edition; "G20") at baseline were included. We implemented a Cox proportion hazard's model to evaluate the associations of different levels of physical activity, sitting time, sleep habits, diet quality, alcohol and coffee consumption, smoking, and body mass index with PD risk, adjusting for several confounding variables.
RESULTS
RESULTS
During a median follow-up of 12.8 years, lifestyle factors including vigorous physical activity (hazard ration [HR] = 0.84; 95% confidence interval [CI], 0.75-0.94), low-to-moderate sitting time (HR = 0.89; 95% CI, 0.81-0.97), and high sleep quality (HR = 0.89; 95% CI, 0.80-0.99) were associated with a reduced risk of PD. Small amounts of coffee (HR = 0.88; 95% CI, 0.82-0.95), red meat (HR = 0.86; 95% CI, 0.76-0.97), and current smoking (HR = 0.65; 95% CI, 0.56-0.75) were also associated with a lower risk of PD, whereas alcohol intake (HR = 1.29; 95% CI, 1.06-1.56) with higher PD risk. Secondary analysis, including metabolic risk factors, confirmed these findings and highlighted the potential protective effect of plasma vitamin D and uric acid, but of low-density lipoprotein-cholesterol, triglycerides, and C-reactive protein as well.
CONCLUSIONS
CONCLUSIONS
Vigorous physical activity, reduced sitting time, good sleep quality together with small coffee intake and vitamin D supplementation are potentially neuroprotective lifestyle interventions for the prevention of PD. © 2024 International Parkinson and Movement Disorder Society.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 International Parkinson and Movement Disorder Society.
Références
Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet 2021;397(10291):2284–2303.
Pezzoli G, Klersy C, Cilia R, et al. Later age at onset in Parkinson's disease over twenty years in an Italian tertiary clinic. Parkinsonism Relat Disord 2014;20(11):1181–1185.
Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 2013;80(22):2035–2041.
Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol 2016;15(12):1257–1272.
Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673–685.
Tsukita K, Sakamaki‐Tsukita H, Takahashi R. Long‐term effect of regular physical activity and exercise habits in patients with early Parkinson disease. Neurology 2022;98(8):e859–e871.
Yoon SY, Suh JH, Yang SN, Han K, Kim YW. Association of Physical Activity, including amount and maintenance, with all‐cause mortality in Parkinson disease. JAMA Neurol 2021;78(12):1446–1453.
Fang X, Han D, Cheng Q, et al. Association of Levels of physical activity with risk of Parkinson disease: a systematic review and meta‐analysis. JAMA Netw Open 2018;1(5):e182421.
Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a promising therapeutic agent in Parkinson's disease. Int J Mol Sci 2020;21(3):1170.
Chatterjee K, Roy A, Banerjee R, et al. Inflammasome and α‐synuclein in Parkinson's disease: a cross‐sectional study. J Neuroimmunol 2020;338:577089.
Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord 2002;17(4):775–781.
Papp A, Horváth A, Virág M, et al. Sleep alterations are related to cognitive symptoms in Parkinson's disease: a 24‐hour ambulatory polygraphic EEG study. Int J Psychophysiol 2022;173:93–103.
Lewis LD. The interconnected causes and consequences of sleep in the brain. Science (New York, NY) 2021;374(6567):564–568.
Si X, Guo T, Wang Z, et al. Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson's disease. NPJ Parkinsons Dis 2022;8(1):54.
Chen H, Huang X, Guo X, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology 2010;74(11):878–884.
Mitchell E, Chohan H, Bestwick JP, Noyce AJ. Alcohol and Parkinson's disease: a systematic review and meta‐analysis. J Parkinsons Dis 2022;12:2369–2381.
Oertel W, Müller H, Schade‐Brittinger C, et al. The NIC‐PD‐study‐a randomized, placebo‐controlled, double‐blind, multi‐centre trial to assess the disease‐modifying potential of transdermal nicotine in early parkinson's disease in Germany and N. America. Mov Dis 2018;33:S159.
Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener 2017;6(1):1–7.
Hong SW, Teesdale‐Spittle P, Page R, Truman P. A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke. Neurotoxicology 2022;93:163–172.
Larsen JP. Sleep disorders in Parkinson's disease. Adv Neurol 2003;91:329–334.
Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007;86(5):1486–1494.
Mesnage R, Bowyer RCE, El Balkhi S, et al. Impacts of dietary exposure to pesticides on faecal microbiome metabolism in adult twins. Environ Health 2022;21(1):46.
Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C. Understanding the links between cardiovascular disease and Parkinson's disease. Mov Disord 2020;35(1):55–74.
Cereda E, Cassani E, Barichella M, et al. Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 2012;31(5):699–704.
Newmark HL, Newmark J. Vitamin D and Parkinson's disease—a hypothesis. Mov Disord 2007;22(4):461–468.